Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 35 holding rows worth $193,700,000.

Accession
0001420506-19-000229
Filed
2019-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 35 entries on the cover page, a total value of $193,700,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $193,700,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HANGER INC41043F208COMMON STOCK1,189,399$22,539,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A253,000$14,193,000thousands by filing date
Cigna Corporation125523100COM73,300$13,921,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM50,000$11,805,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW277,650$10,814,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock103,380$10,723,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM1,062,500$9,403,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM103,000$8,770,000thousands by filing date
ALLERGAN PLCG0177J108SHS61,400$8,207,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK270,146$6,627,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM275,941$6,242,000thousands by filing date
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR62,850$5,766,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS676,104$5,098,000thousands by filing date
TELIGENT INC NEW87960W104COM3,547,607$4,860,000thousands by filing date
EVERFORTH INC COM00191U102Stock87,700$4,780,000thousands by filing date
VIKING THERAPEUTICS INC92686J106COM624,000$4,774,000thousands by filing date
PROVIDENCE SVC CORP743815102COM78,298$4,699,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock316,581$4,445,000thousands by filing date
AXOGEN INC05463X106COM209,088$4,272,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD937,900$4,202,000thousands by filing date
CATALYST BIOSCIENCES INC14888D208COM466,900$3,684,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM2,553,943$3,371,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM404,463$3,357,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock25,000$2,883,000thousands by filing date
MACROGENICS INC556099109COM194,129$2,465,000thousands by filing date
EVOLUS INC30052C107COM195,911$2,331,000thousands by filing date
MILLENDO THERAPEUTICS INC60040X103COM256,739$2,041,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW12,600$1,710,000thousands by filing date
TRIPLE-S MGMT CORP896749108CL B65,515$1,139,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM60,100$1,079,000thousands by filing date
CERECOR INC15671L109COM307,733$994,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM332,846$885,000thousands by filing date
OPTINOSE INC68404V100COM140,314$870,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock245,764$578,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM80,289$173,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-19-000229this filing2019-02-14acceptance time not in the bulk data set